We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NXTT:NASDAQNext Technology Holding Inc. Analysis

Data as of 2026-04-21 - not real-time

$1.85

Latest Price

8/10Risk

Risk Level: High

Executive Summary

NXTT is trading at $1.85, which sits just above its 20‑day SMA (1.81) but well below the 50‑day SMA (2.46), confirming a bearish price trend. The stock’s 30‑day volatility is astronomically high at 281%, and the computed max drawdown of –99.85% underscores extreme price instability. Valuation metrics appear ultra‑cheap: a trailing PE of 0.03 versus an industry average of 36.86, and a price‑to‑book of 0.02 against a book value of $93.31 per share, suggesting the market is severely discounting the company’s assets. However, fundamentals are weak—operating cash flow is negative ($‑3.07M), free cash flow is deeply negative ($‑399.98M), and operating margin sits at –3.58%, indicating ongoing cash‑burn concerns.
The most material catalyst is the recent $157 million registered direct offering announced on March 25 2026, which will dilute existing shareholders and increase capital‑raising risk. Coupled with decreasing volume trends, a low beta (0.34) that masks the underlying volatility, and high sector and geographic exposure (China‑based tech), the stock faces significant downside pressure in the near term despite its seemingly attractive valuation ratios.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Recent $157M direct offering dilutes shareholders
  • Price below 50‑day SMA and bearish technical signals
  • Extreme volatility (281% 30‑day) and decreasing volume

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Ultra‑low valuation (PE 0.03, P/B 0.02) may attract contrarian interest
  • Continued negative operating cash flow and cash‑burn
  • Uncertainty around successful deployment of AI‑enabled services

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Potential upside if AI software services achieve scale
  • Significant asset base relative to market price (book value $93.31 per share)
  • Low beta suggests limited systematic market risk if fundamentals improve

Key Metrics & Analysis

Financial Health

Revenue Growth445.90%
Profit Margin1232.61%
P/E Ratio0.0
ROE53.30%
ROA-16.25%
Debt/Equity0.45
P/B Ratio0.0
Op. Cash Flow$-3074693
Free Cash Flow$-399981600
Industry P/E36.9

Technical Analysis

TrendBearish
RSI44.6
Support$0.45
Resistance$2.81
MA 20$1.81
MA 50$2.46
MA 200$81.52
MACDBullish
VolumeDecreasing
Fear & Greed Index85.98

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.34
Volatility281.43%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.